Volume 8 Issue 2, Feb 2023

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 8 Issue 2, Feb 2023:
Letter
Diffuse midline glioma treated with epigenetic agent-based immunotherapy
Linkai Jing,Zhihong Qian,Qiang Gao,Rui Sun,Zili Zhen,Guihuai Wang,Xuejun Yang,Haitao Li  ORCID: orcid.org/0000-0002-6686-1677,Tiannan Guo  ORCID: orcid.org/0000-0003-3869-7651 &…Wei Zhang